Bio-Path Holdings (BPTH) Stock Overview

Claudine Rigal
Июля 11, 2017

In contrast, the average volume was 8.66 million shares. The oscillator ranges from 0 to -100. For stochastics, readings below 20 are considered oversold and you would only take buy signals if the indicator is below that level.

Current levels places Bio-Path Holdings, Inc. (BPTH) is at 41.83.

Trading volume is a hugely important consideration for any investor. Wall Street analysts covering the stock are projecting that the stock will reach $3.25 within the next 52-weeks. They may also be used to assist the trader figure out proper support and resistance levels for the stock. They now have a United States dollars 7 price target on the stock.

Bio-Path Holdings (NASDAQ:BPTH) shares traded -5.24% down during most recent session to reach at the closing price of $0.38. Institutional investors own 19.88% of the company's stock. Going toward to the 50-day, we can see that shares are now trading -14.40% off of that figure. Consensus earnings estimates are far from ideal, but they are watched by many investors and play an important role in measuring the appropriate valuation for a stock. For the last quarter, the stock has performed -29.78%. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road.

In the last reported quarter, Bio-Path Holdings reported its Actual EPS (earnings per share) of $-0.01/share where most of the analysts working on this stock were estimating the EPS to be $-0.02/share.

Now the shares of Bio-Path Holdings, Inc.

P/E of the company is not reported.

Revenue is the amount of money that a company actually receives during a specific period, including discounts and deductions for returned merchandise.

Bio-Path Holdings, Inc. (BPTH) shows its Return on Assets (ROA) value of -49.2 percent, while the Return on Equity (ROE) value is -65.9 percent and Return on Investment (ROI) value stands at 0 percent. The stock's market capitalization is 36.35M, it has a 52-week low of 0.33 and a 52-week high of 1.89. For the next year, analysts expect that the business will report earnings of ($0.12) per share.

A moving average (MA) is a trend-following or lagging indicator because it is based on past prices.

Multiple company employees have indulged in significant insider trading. The stock's 50 day moving average is $0.42 and its 200-day moving average is $0.77. Commonly, the higher the volatility, the riskier the security. Volatility can either be measured by using the standard deviation or variance between returns from that same security or market index. When we divide the current volume by the three-month average volume, we get a relative volume of 3.82. Finally, Zacks Investment Research upgraded Bio-Path Holdings from a "hold" rating to a "buy" rating and set a $0.75 target price on the stock in a research note on Monday, March 20th. (NASDAQ:BPTH), with 2 analysts believing it is a strong buy. (BPTH) has an Analysts' Mean Recommendation of 2, according to data compiled by Finviz. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale.

Not many analysts have released their opinion on Bio-Path Holdings, Inc. Recently, the stock has been noticed trading -2.24% away from the 20-day moving average.

Bio-Path Holdings (NASDAQ:BPTH) last announced its quarterly earnings results on Thursday, May 11th. (NASDAQ:BPTH)'s stock has been -68.33% and -78.77% for the last 12 months.

D'autres rapports

Discuter de cet article